Status:
COMPLETED
Evaluation of Coagulation Factors and Point-of-care Devices During Veno-venous ECMO Therapy
Lead Sponsor:
University Hospital Goettingen
Conditions:
Extracorporeal Membrane Oxygenation Complication
Coagulation Factor Deficiency
Eligibility:
All Genders
18-90 years
Brief Summary
Hemorrhagic and thromboembolic complications are common in Veno-venous ECMO therapy. The aim of this study is to provide a detailed analysis of the activity of different coagulation factors and change...
Eligibility Criteria
Inclusion
- Need for a Veno-venous extracorporeal membrane oxygenation therapy
Exclusion
- Known coagulation disorders
- Refusal to participate
Key Trial Info
Start Date :
July 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2015
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03754868
Start Date
July 1 2014
End Date
June 1 2015
Last Update
November 27 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center Goettingen
Göttingen, Germany, 37075